Results 101 to 110 of about 115,882 (349)

Prognosis of Ocular Myasthenia Gravis: Retrospective Multicenter Analysis [PDF]

open access: yes, 2015
PURPOSE: To calculate the rate and timing of conversion from ocular myasthenia gravis to generalized myasthenia gravis. DESIGN: Retrospective multicenter analysis. SUBJECTS: Patients included in the study were diagnosed with ocular myasthenia gravis
Abusamra, K   +4 more
core   +1 more source

Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis: A Neuromuscular Surprise

open access: yesCase Reports in Neurological Medicine, 2021
Myasthenia gravis is a neuromuscular autoimmune disease that results in skeletal muscle weakness that worsens after periods of activity and improves after rest.
Hassam Ali   +4 more
doaj   +1 more source

Tensor perturbations in high-curvature string backgrounds [PDF]

open access: yesPhys.Rev. D56 (1997) 4815-4823, 1997
We derive a generalized equation for the evolution of tensor perturbations in a cosmological background, taking into account higher-curvature contributions and a tree-level coupling to the dilaton in the string frame. The equation is obtained by perturbing the gravi-dilaton string effective action, expanded up to first order in $\alpha'$. The $\alpha'$
arxiv   +1 more source

Progress in the therapy of myasthenia gravis: getting closer to effective targeted immunotherapies

open access: yesCurrent Opinion in Neurology, 2020
Purpose of review To provide an update on immunomodulating and immunosuppressive therapies in myasthenia gravis and highlight newly approved, or pending approval, therapies with new biologics.
M. Dalakas
semanticscholar   +1 more source

Severe relapse after cessation of immunosuppressive therapy in a patient with co‐occurrence of neuromyelitis optica spectrum disorder and Sjögren's syndrome: A case report

open access: yesIbrain, EarlyView.
We report a girl with a diagnosis of “neuromyelitis optica spectrum disorder comorbid Sjogren's syndrome” whose condition showed significant improvement after treatment with corticosteroids and immunosuppressive drugs (prednisolone, hydroxychloroquine, and mycophenolate mofetil).
Man‐Min Zhu   +3 more
wiley   +1 more source

Audio-vestibular symptoms in systemic autoimmune diseases [PDF]

open access: yes, 2018
Immune-mediated inner ear disease can be primary, when the autoimmune response is against the inner ear, or secondary. The latter is characterized by the involvement of the ear in the presence of systemic autoimmune conditions. Sensorineural hearing loss
Adelchi, Croce   +7 more
core   +1 more source

Myasthenia gravis as one of paraneoplastic neurological syndromes associated with small cell lung cancer. Case report

open access: yesNeurologijos seminarai, 2018
Myasthenia gravis associated with extrathymic malignancies is a rarely diagnosed pathology in clinical practice. We report a case of myasthenia gravis-like syndrome associated with small cell lung cancer.
R. Bunevičiūtė   +2 more
doaj   +1 more source

On the response of gravitational antennas to dilatonic waves [PDF]

open access: yesPhys.Lett. B470 (1999) 67-72, 1999
It is pointed out that the coupling of macroscopic test masses to the gravi-dilaton background of string theory is non geodesic, in general, and cannot be parametrized by a Brans-Dicke model of scalar-tensor gravity. The response of gravitational antennas to dilatonic waves should be analyzed through a generalized equation of geodesic deviation, taking
arxiv   +1 more source

COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome

open access: yesJournal of Neuromuscular Diseases, 2020
This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any
S. B. Ramaswamy, R. Govindarajan
semanticscholar   +1 more source

Indication‐Specific Dosing and Dose‐Evaluation Strategies in New Indications for Non‐Oncology Monoclonal Antibodies

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Compared to traditional small molecule drugs, monoclonal antibodies (mAbs) often display more complex pharmacokinetic (PK) and pharmacodynamic (PD) properties that may be impacted by disease‐specific factors. For mAbs in non‐oncology indications, where the same drug might be used for conditions involving different organ systems and/or having ...
Sherouk M. Tawfik, Fei Tang
wiley   +1 more source

Home - About - Disclaimer - Privacy